SUICIDE RISK: Asthma Drug SINGULAIR and more
Many drugs currently on the market are commonly prescribed despite their known risks of severe adverse reactions, including suicide. Some of these drugs are marketed without warnings for decades before the FDA finally requires them to carry a”Black Box” warning.
If a drug is a generic version of a name brand, and the name brand had not been required to carry such a warning, generic companies cannot add the warning and, under current law, not responsible for failure to inform customers. This leaves consumers at risk and lacking the ability to make informed consent decisions.
Michael Nevradakis, Ph.D., provided details about Merck’s drug Singulair in the Defender article Merck Knew Its Popular Asthma Drug Could Lead Kids to Commit Suicide, Lawsuits Allege
According to a Reuters investigation, parents trying to sue Merck were “stymied by one of Corporate America’s most effective liability shields: the doctrine of federal preemption” which says federal law and federal regulations supersede state laws, but some are now moving forward. READ ARTICLE
CHD.TV recently interviewed Kim Witczak on the subject of preemption. Kim’s husband, Woody–who was healthy, happy, and excited about his career and future–was put on antidepressants because he was having trouble sleeping. He experienced severe psychological adverse reactions, and his doctor’s recommendation was to simply give the drug another six weeks. Woody did not survive six weeks. Unable to bear the overwhelming drug-induced psychosis, he took his own life. WATCH THE INTERVIEW
Below are important resources regarding the content of the show.
Federal Preemption: A Legal Primer | Congressional Research Service SUMMARY
Kim Witczak’s Twitter | @Woodymatters
Selling Sickness 2013 | PEOPLE BEFORE PROFITS
Woodmatters | Kim Witczak Is A Drug Safety Advocate
Merck Knew Its Popular Asthma Drug Could Lead Kids To Commit Suicide, Lawsuits Allege
A Son Died, His Parents Tried To Sue. How Us Courts Protect Big Pharma
Parents Demand Warning Labels On Popular Asthma Medication Singulair | 7NEWS
Dan Troy On FDA Pre-Emption | CMPI
FDA Chief Counsel Daniel Troy Resigns | California Healthline
Kim Witczak | Antidepressant Testimony
KSTP-TV Kim Witczak / Antidepressants
WCCO-TV I-TEAM Investigation / Kim Witczak
Kim Witczak’s Testimony To Expert Panel On COVID-19 Vaccine Injuries
Vaccine Safety Signals | American Thought Leaders | The Epoch Times
My FDA Testimony Regarding Psychiatric Warnings For Singulair / Montelukast | Youtube @Kimwitczak
Boxed Warning About Mental Health Side Effects For Singulair | FDA
MedWatch: FDA Safety Information & Adverse Event Reporting Program